Article
Novel Acylguanidine-Based Inhibitor of HIV-1.
Journal of virology - 15 Oct 2016
Mwimanzi Philip, Tietjen Ian, Miller Scott C, Shahid Aniqa, Cobarrubias Kyle, Kinloch Natalie N, Baraki Bemuluyigza, Richard Jonathan, Finzi Andrés, Fedida David, Brumme Zabrina L, Brockman Mark A
Abstract excerpt
UNLABELLED: The emergence of transmissible HIV-1 strains with resistance to antiretroviral drugs highlights a continual need for new therapies. Here we describe a novel acylguanidine-containing compound, 1-(2-(azepan-1-yl)nicotinoyl)guanidine (or SM111), that inhibits in vitro replication of HIV-1, including strains resistant to licensed protease, reverse transcriptase, and integrase inhibitors, without major...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
